Skip to main content

To trade in the US, go to polymarket.us

icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

$39,661 Vol.

Dec 31, 2026
Polymarket

$39,661 Vol.

Polymarket

South Sudan

$4,572 Vol.

43%

Rwanda

$2,216 Vol.

22%

Burundi

$229 Vol.

38%

United States

$10,886 Vol.

20%

Canada

$2,307 Vol.

43%

Kenya

$237 Vol.

23%

India

$737 Vol.

44%

Republic of the Congo

$12,408 Vol.

24%

Nigeria

$25 Vol.

50%

Ethiopia

$107 Vol.

52%

Somalia

$129 Vol.

35%

China

$3,853 Vol.

25%

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing 2026 Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, declared in May and now the country’s largest on record with over 7,600 confirmed cases across seven provinces, anchors trader sentiment on the market. Rapid early spread through conflict zones, delayed detection, and limited vaccine efficacy against this strain have driven high implied probabilities for DRC and neighboring Uganda, where roughly 20 linked cases appeared before the localized outbreak concluded. A single imported case reached France with no further transmission. Neighboring nations face elevated cross-border risks from porous borders and displacement, though no sustained community transmission has materialized outside the epicenter as of mid-September. Upcoming catalysts include daily case trends, contact-tracing completion rates, and any new border detections before year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$39,661
End Date
Jan 1, 2027
Market Opened
May 22, 2026, 12:35 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The ongoing 2026 Bundibugyo Ebola outbreak in the Democratic Republic of the Congo, declared in May and now the country’s largest on record with over 7,600 confirmed cases across seven provinces, anchors trader sentiment on the market. Rapid early spread through conflict zones, delayed detection, and limited vaccine efficacy against this strain have driven high implied probabilities for DRC and neighboring Uganda, where roughly 20 linked cases appeared before the localized outbreak concluded. A single imported case reached France with no further transmission. Neighboring nations face elevated cross-border risks from porous borders and displacement, though no sustained community transmission has materialized outside the epicenter as of mid-September. Upcoming catalysts include daily case trends, contact-tracing completion rates, and any new border detections before year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$39,661
End Date
Jan 1, 2027
Market Opened
May 22, 2026, 12:35 PM ET

Resolver

0x65070BE91...

Related

icon for Ebola: new country confirmed before October 1?

Ebola: new country confirmed before October 1?

26%
icon for New pandemic in 2026?

New pandemic in 2026?

6%
icon for New Coronavirus Pandemic in 2026?

New Coronavirus Pandemic in 2026?

6%

Beware of external links.

Frequently Asked Questions

"Which countries will have an Ebola case in 2026?" is a prediction market on Polymarket with 13 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "Uganda" at 100%, followed by "Ethiopia" at 52%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Which countries will have an Ebola case in 2026?" has generated $39.7K in total trading volume since the market launched on May 22, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Which countries will have an Ebola case in 2026?," browse the 13 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Which countries will have an Ebola case in 2026?" is "Uganda" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "Ethiopia" at 52%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Which countries will have an Ebola case in 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.